V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006108 | 10003924 | 1.8 | 78 | Curative (C) | 2017-11-24 | 2018-02-03 | Rituximab (Maintenance) | null | Y | 10354282 | RITUXIMAB |
| 10006109 | 10003926 | 1.71 | 98.8 | null | 2015-05-16 | 2015-05-26 | CHOP R - 21 days | N | N | 10354403 | CHOP R |
| 10006110 | 10003927 | 1.63 | 92.1 | Adjuvant (A) | null | 2018-05-27 | Rituximab (Maintenance) | N | N | 10354499 | RITUXIMAB |
| 10006111 | 10007093 | 1.73 | 72 | Disease modification (D) | 2015-06-04 | 2015-08-29 | FLUOROURACIL + OXALIPLATIN | 01 | N | 10354548 | OXALIPLATIN + MDG |
| 10006112 | 10007093 | 1.59 | 62 | Adjuvant (A) | 2017-01-06 | 2017-01-07 | PACLITAXEL | 2 | N | 10354548 | PACLITAXEL |
| 10006113 | 10007093 | 1.63 | 58.2 | Adjuvant (A) | 2018-09-24 | 2018-09-30 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10354548 | PACLITAXEL |
| 10006114 | 10003930 | 1.8 | 71.3 | Palliative (P) | 2016-01-31 | 2016-02-05 | FLUOROURACIL + IRINOTECAN | N | N | 10354667 | IRINOTECAN + MDG |
| 10006115 | 10007094 | 1.68 | 52.2 | Disease modification (D) | 2018-11-28 | 2018-12-08 | Rituximab | 02 | N | 10354764 | RITUXIMAB |
| 10006116 | 10003931 | 1.7 | 84.999 | Palliative (P) | 2017-12-15 | 2017-12-16 | Rituximab (Maintenance) | 02 | N | 10354769 | RITUXIMAB |
| 10006117 | 10003932 | 1.82 | 75.5 | Curative (C) | 2018-05-12 | 2018-05-16 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10354880 | PACLITAXEL |
| 10006118 | 10003933 | 1.8 | 61.4 | Disease modification (D) | 2014-01-15 | 2014-02-01 | Oxaliplatin + Modified de Gramont | N | N | 10355067 | OXALIPLATIN + MDG |
| 10006119 | 10003934 | 1.65 | 50.6 | Adjuvant (A) | 2018-04-20 | 2018-04-21 | PACLITAXEL | 2 | N | 10355091 | PACLITAXEL |
| 10006120 | 10003935 | 1.64 | 51.2 | Curative (C) | 2016-01-31 | 2016-05-12 | PEMBROLIZUMAB | 99 | null | 10355328 | PEMBROLIZUMAB |
| 10006121 | 10003936 | null | 73.9 | Curative (C) | 2016-06-12 | 2016-06-24 | Trastuzumab Subcutaneous | N | N | 10355528 | TRASTUZUMAB |
| 10006122 | 10003937 | 1.6 | 76.3 | Palliative (P) | 2017-04-09 | 2017-05-21 | CHOP R - 21 days | N | N | 10355563 | CHOP R |
| 10006123 | 10003938 | 1.68 | 50.3 | Curative (C) | 2015-01-12 | 2015-01-27 | Rituximab (Maintenance) | 02 | N | 10355799 | RITUXIMAB |
| 10006124 | 10003938 | 1.68 | 83.4 | Neo-adjuvant (N) | 2018-08-08 | 2018-08-15 | Oxaliplatin + Modified de Gramont | N | N | 10355799 | OXALIPLATIN + MDG |
| 10006125 | 10003939 | 1.84 | 56.6 | null | 2017-05-27 | 2017-06-26 | Docetaxel | 02 | N | 10356131 | DOCETAXEL |
| 10006126 | 10003939 | 1.65 | 70.7 | Palliative (P) | 2013-02-05 | 2013-07-09 | CHOP R | N | Y | 10356131 | CHOP R |
| 10006127 | 10003939 | 1.62 | 97.5 | Palliative (P) | 2014-03-23 | 2014-03-30 | Capecitabine + Oxaliplatin 21day | 02 | N | 10356131 | CAPECITABINE + OXALIPLATIN |
| 10006128 | 10003939 | 1.77 | 71 | Adjuvant (A) | 2017-04-13 | 2017-04-18 | Trastuzumab 21 day maintenance | 2 | null | 10356131 | TRASTUZUMAB |
| 10006129 | 10009244 | 1.6 | 75.2 | Curative (C) | 2018-11-19 | 2018-12-10 | Docetaxel | 02 | N | 10356735 | DOCETAXEL |
| 10006130 | 10003940 | 1.73 | 70 | Palliative (P) | 2018-03-30 | 2018-03-30 | Trastuzumab Subcutaneous | 02 | N | 10357304 | TRASTUZUMAB |
| 10006131 | 10003941 | 1.84 | 72 | Palliative (P) | 2017-12-12 | 2017-12-13 | CHOP R | 02 | N | 10357304 | CHOP R |
| 10006132 | 10003942 | 1.6 | 68 | Disease modification (D) | 2018-01-04 | 2018-09-29 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 10358087 | PACLITAXEL |
| 10006133 | 10003943 | null | 93 | Curative (C) | 2018-01-21 | 2018-01-23 | CHOP R | N | N | 10358101 | CHOP R |
| 10006134 | 10003943 | null | 75.2 | Palliative (P) | 2018-12-05 | 2018-12-05 | Docetaxel 100mg/m2 (21 day) | 2 | N | 10358101 | DOCETAXEL |
| 10006135 | 10003945 | 1.68 | 61.6 | Curative (C) | 2015-02-08 | 2015-02-08 | Irinotecan + Modified De Gramont | 02 | Y | 10358397 | IRINOTECAN + MDG |
| 10006136 | 10003945 | 1.66 | 104 | Neo-adjuvant (N) | 2017-06-22 | 2017-07-15 | Rituximab | 2 | null | 10358397 | RITUXIMAB |
| 10006137 | 10003949 | 1.8 | null | Adjuvant (A) | 2018-02-17 | 2018-02-20 | PEMBROLIZUMAB | 2 | N | 10359592 | PEMBROLIZUMAB |
| 10006138 | 10003949 | 1.62 | 97.5 | Curative (C) | null | 2017-03-02 | Docetaxel 75mg/m2 (21 day) | N | N | 10359592 | DOCETAXEL |
| 10006139 | 10003949 | 1.66 | 101.5 | Disease modification (D) | 2017-08-04 | 2017-08-04 | Oxaliplatin + Modified de Gramont | N | N | 10359592 | OXALIPLATIN + MDG |
| 10006140 | 10003951 | 1.84 | 50 | Palliative (P) | 2018-10-07 | 2018-10-21 | Rituximab | N | N | 10359780 | RITUXIMAB |
| 10006141 | 10003952 | 1.6 | 79 | Adjuvant (A) | 2017-09-19 | 2017-09-19 | Oxaliplatin + Modified de Gramont | 02 | N | 10359780 | OXALIPLATIN + MDG |
| 10006142 | 10003953 | 1.61 | 80.8 | Palliative (P) | 2018-09-22 | 2018-09-23 | TRASTUZUMAB | N | null | 10359931 | TRASTUZUMAB |
| 10006143 | 10003953 | 1.79 | 71.3 | Palliative (P) | 2017-07-24 | 2017-07-29 | TRASTUZUMAB | N | Y | 10359931 | TRASTUZUMAB |
| 10006144 | 10003953 | 1.58 | 69.6 | Adjuvant (A) | 2018-10-27 | 2018-10-27 | TRASTUZUMAB | N | N | 10359931 | TRASTUZUMAB |
| 10006145 | 10003954 | 1.77 | 75.2 | Palliative (P) | 2013-07-14 | 2013-07-20 | Trastuzumab Subcutaneous | 02 | N | 10360544 | TRASTUZUMAB |
| 10006146 | 10003956 | 1.76 | 93 | Disease modification (D) | 2018-09-22 | 2018-09-26 | Docetaxel 75mg/m2 (21 day) | N | N | 10360601 | DOCETAXEL |
| 10006147 | 10003958 | 1.84 | null | Not known (9) | 2017-05-10 | 2017-05-19 | PACLITAXEL | N | N | 10360891 | PACLITAXEL |
| 10006148 | 10003958 | 1.6 | 64 | Palliative (P) | 2018-04-03 | 2018-04-03 | Rituximab | Y | null | 10360891 | RITUXIMAB |
| 10006149 | 10003959 | 1.5 | 55.8 | Disease modification (D) | 2018-03-29 | 2018-04-04 | CHOP R - 21 days | 02 | N | 10361122 | CHOP R |
| 10006150 | 10003961 | 1.75 | 76.4 | Palliative (P) | 2018-07-09 | 2019-01-31 | TRASTUZUMAB | N | N | 10361135 | TRASTUZUMAB |
| 10006151 | 10003962 | 1.77 | 92 | Adjuvant (A) | 2018-04-03 | 2018-04-25 | FLUOROURACIL + OXALIPLATIN | 02 | N | 10361280 | OXALIPLATIN + MDG |
| 10006152 | 10003963 | 1.71 | 77.8 | Curative (C) | 2017-10-08 | 2017-10-08 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 10361351 | PACLITAXEL |
| 10006153 | 10003964 | 0 | 91.3 | Neo-adjuvant (N) | 2018-09-29 | 2018-09-29 | Docetaxel 100mg/m2 (21 day) | 02 | N | 10361383 | DOCETAXEL |
| 10006154 | 10003964 | 1.85 | 74.799 | Curative (C) | 2017-11-18 | 2017-11-19 | Rituximab | N | N | 10361383 | RITUXIMAB |
| 10006155 | 10003964 | null | 78.7 | Disease modification (D) | 2016-03-20 | 2016-03-20 | Rituximab | N | N | 10361383 | RITUXIMAB |
| 10006156 | 10003965 | 1.68 | 63.6 | Disease modification (D) | 2019-03-18 | 2019-03-18 | Rituximab | 99 | N | 10361500 | RITUXIMAB |
| 10006157 | 10003966 | 1.68 | 94 | Palliative (P) | 2014-03-20 | 2014-03-20 | Docetaxel | N | N | 10361742 | DOCETAXEL |